Rapport Therapeutics, Inc. (RAPP) Discusses Phase II Bipolar Mania Trial Results and Business Update Transcript

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The reports are tied to Global. The first report grouped here was at 20 Oct 2026, 20:54 UTC. The headline in use is “Rapport Therapeutics, Inc. (RAPP) Discusses Phase II Bipolar Mania Trial Results and Business Update Transcript”. This note is SignalsMonitor's own briefing, not the publisher's article.